Magnetically modified-mitoxantrone mesoporous organosilica drugs: an emergent multimodal nanochemotherapy for breast cancer

Abstract Background Chemotherapy, the mainstay treatment for metastatic cancer, presents serious side effects due to off-target exposure. In addition to the negative impact on patients’ quality of life, side effects limit the dose that can be administered and thus the efficacy of the drug. Encapsula...

Descrición completa

Detalles Bibliográficos

Principais autores:	Eva Romaní -Cubells, Samuel Martínez-Erro, Victoria Morales, Ana Chocarro-Calvo, José M. García-Martínez, Raúl Sanz, Custodia García-Jiménez, Rafael A. García-Muñoz
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2024-05-01
Series:	Journal of Nanobiotechnology
Assuntos:	Periodic mesoporous organosilica (PMO) Magnetic mesoporous organosilica drugs (MOD) Drug delivery systems Mitoxantrone Breast cancer treatment Magnetic nanomedicine
Acceso en liña:	https://doi.org/10.1186/s12951-024-02522-4
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!